Arnold & Porter Leads Pfizer Deal Worth Up To $810M
Pharmaceutical giant Pfizer, led by Arnold & Porter, said Wednesday it has agreed to acquire the Swiss clinical-stage biotechnology company Therachon Holding AG in a deal worth up to $810 million....To view the full article, register now.
Already a subscriber? Click here to view full article